Multidrug resistance in Candida albicans: disruption of the BENr gene.
AUTOR(ES)
Goldway, M
RESUMO
The BENr gene of Candida albicans, which confers resistance on susceptible strains of Saccharomyces cerevisiae to six structurally and functionally unrelated drugs, was described recently (R. Ben-Yaacov, S. Knoller, G. Caldwell, J. M. Becker, and Y. Koltin, Antimicrob. Agents Chemother. 38:648-652, 1994). This gene bears similarity to membrane proteins encoding antibiotic resistance in prokaryotes and eukaryotes. The effect of disruption of this gene on viability and drug susceptibility was determined. The results indicate that the gene is not essential but its inactivation leads to susceptibility to three of the four drugs tested. Inactivation of this gene did not increase the susceptibility of the mutant to benomyl, suggesting that C. albicans has other mechanisms of resistance, some of which may be additional efflux pumps that confer resistance to this tubulin-destabilizing agent.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=162553Documentos Relacionados
- Candida albicans gene encoding resistance to benomyl and methotrexate is a multidrug resistance gene.
- Directed mutagenesis in Candida albicans: one-step gene disruption to isolate ura3 mutants.
- Reversible fluconazole resistance in Candida albicans: a potential in vitro model.
- Candida Albicans: The Pathogenic Fungus
- Reduced virulence of Candida albicans mutants affected in multidrug resistance.